Torthaí cuardaigh - Stephen D. Wiviott

Beachtaigh na torthaí
  1. 1
    Clopidogrel Response Variability and Future Therapies

    Clopidogrel Response Variability and Future Therapies de réir Michelle L. O’Donoghue, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

    Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events de réir Marc S. Sabatine, Robert P. Giugliano, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Efficacy and safety of dapagliflozin according to baseline blood pressure – observations from DECLARE-TIMI 58 Trlial

    Efficacy and safety of dapagliflozin according to baseline blood pressure – observations from DECLARE-TIMI 58 Trlial de réir Remo Furtado, Itamar Raz, Erica L. Goodrich, Marc S. Sabatine, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Race and Sex Differences in Management and Outcomes of Patients After <scp>ST</scp>‐Elevation and Non–<scp>ST</scp>‐Elevation Myocardial Infarct: Results From the <scp>NCDR</scp>

    Race and Sex Differences in Management and Outcomes of Patients After <scp>ST</scp>‐Elevation and Non–<scp>ST</scp>‐Elevation Myocardial Infarct: Results From the <scp>NCDR</scp>... de réir D. Edmund Anstey, Shuang Li, Laine Thomas, Tracy Y. Wang, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels

    Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels de réir Marc S. Sabatine, Stephen D. Wiviott, Canqing Yu, Sabina A. Murphy, Robert P. Giugliano

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Short-Term Outcomes of Acute Myocardial Infarction in Patients With Acute Kidney Injury

    Short-Term Outcomes of Acute Myocardial Infarction in Patients With Acute Kidney Injury de réir Caroline S. Fox, Paul Muntner, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Characteristics and In-Hospital Outcomes of Patients With Non–ST-Segment Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

    Characteristics and In-Hospital Outcomes of Patients With Non–ST-Segment Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention de réir Elias B. Hanna, Anita Y. Chen, Matthew T. Roe, Stephen D. Wiviott, Caroline S. Fox, Jorge F. Saucedo

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy de réir Stephen D. Wiviott, Christopher P. Cannon, David A. Morrow, Kausik K. Ray, Marc A. Pfeffer, Eugene Braunwald

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

    DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction de réir Larry S. Dean, Robert W. Yeh, Joseph M. Massaro, Donald E. Cutlip, Philippe Gabríel Steg, Stephen D. Wiviott, Laura Mauri

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry

    Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry de réir Matthew W. Sherwood, Stephen D. Wiviott, S. Andrew Peng, Matthew T. Roe, James A. deLemos, Eric D. Peterson, Tracy Y. Wang

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention

    Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention de réir Elizabeth M. Mahoney, Kaijun Wang, Suzanne V. Arnold, Irina Proskorovsky, Stephen D. Wiviott, Elliott M. Antman, Eugene Braunwald, David J. Cohen

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Risk of Heart Failure Complication During Hospitalization for Acute Myocardial Infarction in a Contemporary Population

    Risk of Heart Failure Complication During Hospitalization for Acute Myocardial Infarction in a Contemporary Population de réir Ravi V. Shah, DaJuanicia N. Holmes, Monique Anderson, Tracy Y. Wang, Michael C. Kontos, Stephen D. Wiviott, Benjamin M. Scirica

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

    Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions de réir Michael G. Silverman, Brian A. Ference, Canqing Yu, Stephen D. Wiviott, Robert P. Giugliano, Scott M. Grundy, Eugene Braunwald, Marc S. Sabatine

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

    Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis de réir Jessica L. Mega, Sandra Close, Stephen D. Wiviott, Lei Shen, Joseph R. Walker, Tabassome Simon, Elliott M. Antman, Eugene Braunwald, Marc S. Sabatine

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes

    Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes de réir Nicholas Marston, Robert P. Giugliano, Canqing Yu, Michael G. Silverman, Michelle L. O’Donoghue, Stephen D. Wiviott, Brian A. Ference, Marc S. Sabatine

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Comparison of the Prognostic Value of Peak Creatine Kinase‐MB and Troponin Levels Among Patients With Acute Myocardial Infarction: A Report from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines

    Comparison of the Prognostic Value of Peak Creatine Kinase‐MB and Troponin Levels Among Patients With Acute Myocardial Infarction: A Report from the Acute Coronary Treatment and In... de réir Chee Tang Chin, Tracy Y. Wang, Shuang Li, Stephen D. Wiviott, James A. deLemos, Michael C. Kontos, Eric D. Peterson, Matthew T. Roe

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression

    Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression de réir Yuri B. Pride, Patricia Tung, Satishkumar Mohanavelu, Cafer Zorkun, Stephen D. Wiviott, Elliott M. Antman, Robert P. Giugliano, Eugene Braunwald, C. Michael Gibson

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease

    Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kid... de réir Caroline S. Fox, Paul Muntner, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Christopher P. Cannon, Jorge F. Saucedo, Michael C. Kontos, Stephen D. Wiviott

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia

    Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia de réir Michael J. Koren, Marc S. Sabatine, Robert P. Giugliano, Gisle Langslet, Stephen D. Wiviott, Helina Kassahun, Andrea Ruzza, Yuhui Ma, Ransi Somaratne, Frederick J. Raal

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction

    Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction de réir Mitul B. Kadakia, Nihar R. Desai, Karen P. Alexander, Anita Y. Chen, JoAnne M. Foody, Christopher P. Cannon, Stephen D. Wiviott, Benjamin M. Scirica

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: